Vascular Solutions Inc. offers the EXPRO Elite Snare, a one-piece medical device designed for the retrieval and manipulation of objects located in the cardiovascular system, including coils, balloons, catheters and guide wires.

St. Jude Medical said the FDA cleared its SJM Confirm implantable cardiac monitor (ICM), a compact device designed to help physicians diagnose abnormal heart rhythms.

GE Healthcare’s recently released Vivid E9 ultrasound features Accelerated Volume Architecture (AVA), which not only makes single beat acquisition possible but, working alongside Extended Signal transducer technology in each probe, it reportedly delivers a leap in 2D, 4D and shared service image quality across the entire patient population.


There have been numerous new products released in the past year to enhance implantable pacing and defibrillation devices, but new advances in remote monitoring seem to be paving the way of the future.

There is skepticism among cardiologists whether flat panel detectors can help lower the X-ray dose more than using traditional image intensifiers in the cath lab. There was a story concerning this in the last issue of DAIC which said flat panel detectors are replacing image intensifiers partly because they help lower the X-ray exposure to patients.

October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.

October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting Coronary Stent System based on the product's design and strong clinical data, the next-generation drug eluting stent represents a significant advance in the treatment of coronary artery disease.

October 30, 2008 - Thoratec Corp. this week notified healthcare professionals of a worldwide correction of the HeartMate II Left Ventricular Assist System (HM II LVAS), of all serial numbers (having catalog numbers 1355 or 102139), distributed since the beginning of clinical studies in November 2003.

October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in treating fluid overload in heart failure patients were presented at the recent Heart Failure Society of America (HFSA) 2008 Annual Scientific Meeting in Toronto, Canada.

The company’s Aquapheresis therapy is a simplified method for safely and effectively removing the excess salt and water in patients with fluid overload. The company said the independent studies continue to validate the results of earlier research.

October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in-man trials were released Oct. 13 at TCT, marking an important milestone for Cappella.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now